Adverse Reactions and Clinical Issues of Pyridostigmine Bromide in Treatment of Myasthenia Gravis
Pyridostigmine bromide is a first-line drug for the treatment of myasthenia gravis(MG).In clinical application,its therapeutic effects are not good on all subtypes of MG,especially in the treatment of special groups for which no norms can yet be found.This article elaborates on the adverse reactions and current clinical problems of pyridostigmine bromide in the treatment of MG,and proposes possible solutions to provide reference for improving MG treatment plans in the future.
Pyridostigmine bromideMyasthenia gravisAdverse reactionsClinical problem
NETL
NSTL
万方数据
